Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets
- Recalling company
- Teva Pharmaceuticals USA, Inc
- Product
- Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
- Reason
- Presence of Foreign Tablets/Capsules
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Sep 29, 2026
- Reported
- Oct 21, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 240,448 cartons
- Lot / codes
- Lot, expiry: [100 Tablets] Lots 8634085, 8635085, 8636085, exp 07/2027; [500 Tablets] Lot 8633085, exp 07/2027
- Company location
- Parsippany, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0038-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0038-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.